Electroacupuncture diminishes p2x2 and p2x3 purinergic receptor expression in dorsal root ganglia of rats with visceral hypersensitivity

Neural Regeneration Research

Volumn 8, Issue 9, 2013, Pages 802-808

  Weng, Zhi Jun ^a   Wu, Lu Yi ^a   Lu, Yuan ^a   Wang, Li Dong ^a   Tan, Lin Ying ^a   Dong, Ming ^a   Xin, Yu Hu ^b  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Abdominal withdrawal reflex scores; Acupuncture and moxibustion; Electroacupuncture; Grants supported paper; Irritable bowel syndrome; Neural regeneration; Neuroregeneration; P2 purinergic receptors; Peripheral nerve injury; Photographs containing paper; Visceral hypersensitivity

Indexed keywords

PURINERGIC P2X2 RECEPTOR; PURINERGIC P2X3 RECEPTOR;

ABDOMINAL REFLEX; ABDOMINAL WITHDRAWAL REFLEX SCORE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON DILATATION; ELECTROACUPUNCTURE; FEMALE; HYPERSENSITIVITY; IMMUNOHISTOCHEMISTRY; IRRITABLE COLON; MALE; NERVE STIMULATOR; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; RAT; SPINAL GANGLION; VISCERAL HYPERSENSITIVITY;

EID: 84890826988     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2013.09.004     Document Type: Article

References (55)

1. Kanazawa M, Hongo M, Fukudo S. Visceral hypersensitivity in irritable bowel syndrome. J Gastroenterol Hepatol. 2011;26 Suppl 3:119-121.
2. Keszthelyi D, Troost FJ, Masclee AA. Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012;303(2):G141-154.
3. Mathew P, Bhatia SJ. Pathogenesis and management of irritable bowel syndrome. Trop Gastroenterol. 2009;30(1): 19-25.
4. Kang MX, Jia H. Progress in mechanisms of visceral hypersensitivity in irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi. 2008;16(14):1554-1558.
5. Elsenbruch S. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms. Brain Behav Immun. 2011;25(3):386-394.
6. Grundy D. Speculations on the structure/function relationship for vagal and splanchnic afferent endings supplying the gastrointestinal tract. J Auton Nerv Syst. 1988;22(3):175-180.
7. Furness JB, Clerc N, Kunze WA. Memory in the enteric nervous system. Gut. 2000;47 Suppl 4:iv60-62;iv76.
8. Szurszewski JH, Ermilov LG, Miller SM. Prevertebral ganglia and intestinofugal afferent neurones. Gut. 2002;51 Suppl 1:i6-10.
9. Burnstock G. Introductory overview of purinergic signalling. Front Biosci (Elite Ed). 2011;3:896-900.
10. Burnstock G. The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology. 1997;36(9):1127-1139.
11. Shieh CC, Jarvis MF, Lee CH, et al. P2X receptor ligands and pain. Expert Opin Ther Pat. 2006;16(8):1113-1127.
12. Burnstock G. Purinergic P2 receptors as targets for novel analgesics. Pharmacol Ther. 2006;110(3):433-454.
13. Yu Q, Zhao Z, Sun J, et al. Expression of P2X6 receptors in the enteric nervous system of the rat gastrointestinal tract. Histochem Cell Biol. 2010;133(2):177-188.
14. Xu GY, Huang LY. Peripheral inflammation sensitizes P2X receptor-mediated responses in rat dorsal root ganglion neurons. J Neurosci. 2002;22(1):93-102.
15. Khakh BS, Burnstock G, Kennedy C, et al. International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev. 2001;53(1):107-118.
16. Burnstock G. Purinergic mechanosensory transduction and visceral pain. Mol Pain. 2009;5:69.
17. Burnstock G. Purine-mediated signalling in pain and visceral perception. Trends Pharmacol Sci. 2001;22(4): 182-188.
18. Burnstock G. Targeting the visceral purinergic system for pain control. Curr Opin Pharmacol. 2012;12(1):80-86.
19. Dunn PM, Zhong Y, Burnstock G. P2X receptors in peripheral neurons. Prog Neurobiol. 2001;65(2): 107-134.
20. Ruan HZ, Burnstock G. Localisation of P2Y1 and P2Y4 receptors in dorsal root, nodose and trigeminal ganglia of the rat. Histochem Cell Biol. 2003;120(5):415-426.
21. Lin SY, Corey DP. TRP channels in mechanosensation. Curr Opin Neurobiol. 2005;15(3):350-357.
22. Xu GY, Shenoy M, Winston JH, et al. P2X receptor- mediated visceral hyperalgesia in a rat model of chronic visceral hypersensitivity. Gut. 2008;57(9):1230-1237.
23. Cooke HJ. Neuroimmune signaling in regulation of intestinal ion transport. Am J Physiol. 1994;266(2 Pt 1): G167-178.
24. Burnstock G. Purines and sensory nerves. Handb Exp Pharmacol. 2009;(194):333-392.
25. Cao HL, Gao J, Jin ZD, et al. Effect of intrathecal injection of trinitrophenyl adenosine triphosphate on visceral hypersensitivity in rats. Wei Chang Bing Xue. 2007;12(6): 344-348.
26. Manheimer E, Wieland LS, Cheng K, et al. Acupuncture for irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol. 2012;107(6): 835-848.
27. Manheimer E, Cheng K, Wieland LS, et al. Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2012;5:CD005111.
28. Zhu WL, Li Y, Wei HF, et al. Effect of electro-acupuncture at different acupoints on neuropeptide and somatostatin in rat brain with irritable bowel syndrome. Chin J Integr Med. 2012;18(4):288-292.
29. Zhang HS, Wang FC. Application of combination of he-mu points and combination of shu-yuan in syndrome differentiation of zang- and fu-organs. Zhongguo Zhenjiu. 2006;26(5):378-380.
30. Wu HG, Zhou LB, Pan YY, et al. Study of the mechanisms of acupuncture and moxibustion treatment for ulcerative colitis rats in view of the gene expression of cytokines. World J Gastroenterol. 1999;5(6):515-517.
31. Wu HG, Zhou LB, Shi DR, et al. Morphological study on colonic pathology in ulcerative colitis treated by moxibustion. World J Gastroenterol. 2000;6(6):861-865.
32. Wu HG, Gong X, Yao LQ, et al. Mechanisms of acupuncture and moxibustion in regulation of epithelial cell apoptosis in rat ulcerative colitis. World J Gastroenterol. 2004;10(5):682-688.
33. Wu HG, Liu HR, Tan LY, et al. Electroacupuncture and moxibustion promote neutrophil apoptosis and improve ulcerative colitis in rats. Dig Dis Sci. 2007;52(2):379-384.
34. Shi Y, Zhou EH, Wu HG, et al. Moxibustion treatment restoring the intestinal epithelium barrier in rats with Crohn's disease by down-regulating tumor necrosis factor alpha, tumor necrosis factor receptor 1, and tumor necrosis factor receptor 2. Chin J Integr Med. 2011;17(3): 212-217.
35. Bao CH, Wu LY, Shi Y, et al. Moxibustion down-regulates colonic epithelial cell apoptosis and repairs tight junctions in rats with Crohn's disease. World J Gastroenterol. 2011; 17(45):4960-4970.
36. Bao CH, Wu LY, Wu HG, et al. Moxibustion inhibits apoptosis and tumor necrosis factor-alpha/tumor necrosis factor receptor 1 in the colonic epithelium of Crohn's disease model rats. Dig Dis Sci. 2012;57(9):2286-2295.
37. Burnstock G. Acupuncture: a novel hypothesis for the involvement of purinergic signalling. Med Hypotheses. 2009;73(4):470-472.
38. Gourine AV, Wood JD, Burnstock G. Purinergic signalling in autonomic control. Trends Neurosci. 2009;32(5): 241-248.
39. Zhao ZQ. Neural mechanism underlying acupuncture analgesia. Prog Neurobiol. 2008;85(4):355-375.
40. Yu XJ, Ding GH, Yao W, et al. The role of collagen fiber in "Zusanli" (ST 36) in acupuncture analgesia in the rat. Zhongguo Zhen Jiu. 2008;28(3):207-213.
41. Labrakakis C, Gerstner E, MacDermott AB. Adenosine triphosphate-evoked currents in cultured dorsal root ganglion neurons obtained from rat embryos: desensitization kinetics and modulation of glutamate release. Neuroscience. 2000;101(4):1117-1126.
42. Hamilton SG, McMahon SB. ATP as a peripheral mediator of pain. J Auton Nerv Syst. 2000;81(1-3):187-194
43. Dowd E, McQueen DS, Chessell IP, et al. P2X receptor- mediated excitation of nociceptive afferents in the normal and arthritic rat knee joint. Br J Pharmacol. 1998;125(2): 341-346.
44. Chen CC, Akopian AN, Sivilotti L, et al. A P2X purinoceptor expressed by a subset of sensory neurons. Nature. 1995;377(6548):428-431.
45. Wu HG, Jiang B, Zhou EH, et al. Regulatory mechanism of electroacupuncture in irritable bowel syndrome: preventing MC activation and decreasing SP VIP secretion. Dig Dis Sci. 2008;53(6):1644-1651.
46. Liu HR, Wang XM, Zhou EH, et al. Acupuncture at both ST25 and ST37 improves the pain threshold of chronic visceral hypersensitivity rats. Neurochem Res. 2009; 34(11):1914-1918.
47. Zhou EH, Liu HR, Wu HG, et al. Suspended moxibustion relieves chronic visceral hyperalgesia via serotonin pathway in the colon. Neurosci Lett. 2009;451(2):144-147.
48. Zhou EH, Liu HR, Wu HG, et al. Herb-partition moxibustion relieves chronic visceral hyperalgesia and 5-HT concentration in colon mucosa of rats. Neurol Res. 2009;31(7):734-737.
49. Zhou EH, Wang XM, Ding GH, et al. Suspended moxibustion relieves chronic visceral hyperalgesia and decreases hypothalamic corticotropin-releasing hormone levels. World J Gastroenterol. 2011;17(5):662-665.
50. Ma XP, Tan LY, Yang Y, et al. Effect of electro-acupuncture on substance P, its receptor and corticotropin-releasing hormone in rats with irritable bowel syndrome. World J Gastroenterol. 2009;15(41):5211-5217.
51. Wu HG, Liu HR, Zhang ZA, et al. Electro-acupuncture relieves visceral sensitivity and decreases hypothalamic corticotropin-releasing hormone levels in a rat model of irritable bowel syndrome. Neurosci Lett. 2009;465(3): 235-237.
52. Liu HR, Qi L, Wu LY, et al. Effects of moxibustion on dynorphin and endomorphin in rats with chronic visceral hyperalgesia. World J Gastroenterol. 2010;16(32): 4079-4083.
53. The Ministry of Science and Technology of the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.
54. Li ZR. Experimental Acupuncture. Beijing: China Press of Traditional Chinese Medicine. 2007.
55. Al-Chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology. 2000;119(5):1276-1285.